ATE342720T1 - Kombination aus quetiapin und zolmitriptan - Google Patents

Kombination aus quetiapin und zolmitriptan

Info

Publication number
ATE342720T1
ATE342720T1 AT02760969T AT02760969T ATE342720T1 AT E342720 T1 ATE342720 T1 AT E342720T1 AT 02760969 T AT02760969 T AT 02760969T AT 02760969 T AT02760969 T AT 02760969T AT E342720 T1 ATE342720 T1 AT E342720T1
Authority
AT
Austria
Prior art keywords
zolmitriptan
quetiapine
combination
sub
treatment
Prior art date
Application number
AT02760969T
Other languages
English (en)
Inventor
David Lee
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE342720T1 publication Critical patent/ATE342720T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT02760969T 2001-08-27 2002-08-23 Kombination aus quetiapin und zolmitriptan ATE342720T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102855A SE0102855D0 (sv) 2001-08-27 2001-08-27 Method of treatment

Publications (1)

Publication Number Publication Date
ATE342720T1 true ATE342720T1 (de) 2006-11-15

Family

ID=20285147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760969T ATE342720T1 (de) 2001-08-27 2002-08-23 Kombination aus quetiapin und zolmitriptan

Country Status (12)

Country Link
US (2) US20050020571A1 (de)
EP (1) EP1423112B1 (de)
JP (1) JP2005503391A (de)
AT (1) ATE342720T1 (de)
AU (1) AU2002326271B2 (de)
CA (1) CA2456480A1 (de)
DE (1) DE60215525T2 (de)
ES (1) ES2274081T3 (de)
NZ (1) NZ530930A (de)
SE (1) SE0102855D0 (de)
WO (1) WO2003018009A1 (de)
ZA (1) ZA200401550B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160033796A (ko) * 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
JP2012506404A (ja) * 2008-10-22 2012-03-15 ノバルティス アーゲー 片頭痛処置用組み合わせ剤
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
US10457299B2 (en) * 2017-02-22 2019-10-29 Westinghouse Air Brake Technologies Corporation Train stop timer
US9993486B1 (en) 2017-06-19 2018-06-12 Tlc Therapeutics, Llc Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
JP2000507544A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 痛みの治療方法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
GB9709815D0 (en) * 1997-05-14 1997-07-09 Merck Sharp & Dohme Therapeutic method
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
GB9928578D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations

Also Published As

Publication number Publication date
AU2002326271B2 (en) 2007-10-11
JP2005503391A (ja) 2005-02-03
WO2003018009A1 (en) 2003-03-06
US20080108596A1 (en) 2008-05-08
DE60215525T2 (de) 2007-06-06
EP1423112A1 (de) 2004-06-02
DE60215525D1 (de) 2006-11-30
EP1423112B1 (de) 2006-10-18
CA2456480A1 (en) 2003-03-06
SE0102855D0 (sv) 2001-08-27
ES2274081T3 (es) 2007-05-16
US20050020571A1 (en) 2005-01-27
NZ530930A (en) 2006-01-27
ZA200401550B (en) 2004-11-17

Similar Documents

Publication Publication Date Title
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
SE0104341D0 (sv) New use
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
ATE384058T1 (de) Thiazolderivate
TNSN07063A1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
EP1841426A4 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer-krankheit
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
DE60209511D1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
HUS000503I2 (hu) Midosztaurin vagy annak egy sója
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
EP1562897A4 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
ATE301654T1 (de) Naphthyridinderivate
MXPA05008838A (es) Formulaciones de absorcion acelerada del agonista selectivo de la 5-ht.
TW200517107A (en) Novel formulation
DE602007011975D1 (de) Thiadiazolderivate zur behandlung neurodegenerativer krankheiten
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
DE60215525D1 (de) Kombination aus quetiapin und zolmitriptan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties